Skip to content

UroGen Pharma Ltd

US · URGN #2773 by market cap Listed 2017
40.70 -0.73 -1.76%
Live - 5344 symbols - heartbeat 490s ago · 2026-10-08 05:49
Pre-market 40.90 +0.49%
After-hours 40.50 -0.49%
Market cap
1.99B
P/B
-15.02
EPS
-3.19
Reader sentiment Are you bullish or bearish on URGN?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Ladenburg Thalmann Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $43
    Market Newswire · 2026/5/11
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/19
  • A Quick Look at Today's Ratings for UroGen Pharma Ltd(URGN.US), With a Forecast Between $48 to $75
    Market Newswire · 2026/8/6
  • Rating change
    Urogen Pharma (URGN) Receives a Buy From H.C. Wainwright
    TipRanks · 2026/5/27
  • Goldman Sachs Maintains UroGen Pharma Ltd(URGN.US) With Hold Rating, Raises Target Price to $44
    Market Newswire · 2026/7/16
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/5/7
  • Guggenheim Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $42
    Market Newswire · 2026/7/22
  • Rating change
    Piper Sandler Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/4/20
  • Rating change
    H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/4/23
  • Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/8/6
  • Rating change
    TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/22
  • Rating change
    Piper Sandler Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/2/13
  • Rating change
    Ladenburg Thalmann Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2025/11/8
  • Rating change
    Jefferies Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $40
    Market Newswire · 2026/4/10
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/8/21
  • Rating change
    TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/6/16
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/16
  • Rating change
    Guggenheim Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/2/2
  • Rating change
    H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/5/11
  • Rating change
    H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/16

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 05:49:07 · For reference only, not investment advice and not tailored to your situation.